Receive Breaking News updates as they occur
(Reuters) - A federal judge in California on Thursday denied a request by Allergan Inc to expedite its civil suit claiming that Valeant Pharmaceuticals International Inc and Pershing Square Capital Management engaged in insider trading ahead of their bid to buy Allergan. Judge David Carter said the U.S. District Court for the Central District of California "would be reluctant to create a precedent that allows corporations to demand at will the immediate attention and input of the federal courts in order to resolve intra-corporate disputes that might be better left to the dynamic free market or to the state court." Valeant and Pershing Square made an offer for Botox maker Allergan in April, which the company has rejected. Allergan has fought the takeover attempt and on Aug. 1 filed a civil insider trading lawsuit against the companies, saying that the unusual partnership between them violated securities regulations.
Journalist James Foley's jihadist captors sent his family a taunting and rambling email threatening to kill him, just a week before making public a video of his execution, the American reporter's employer said. GlobalPost said on Thursday it released the full text of the email from Islamic State (IS) militants "in the interest of transparency and to fully tell Jim's story." "We believe the text offers insight into the motivations and tactics of the Islamic State," it added.